List of VMAT2 inhibitors - Drugs.com
VMAT2 inhibitors (vesicular monoamine transporter-2 inhibitors) are used to treat movement disorders such as Huntington’s disease or tardive dyskinesia.
Vesicular Monoamine Transporter 2 (VMAT2) Inhibitors
Apr 2, 2019 · Valbenazine (val ben' a zeen) is an inhibitor of synaptic vesicular monoamine transporter 2 (VMAT2), the inhibition of which causes a depletion of neuroactive monoamines …
VMAT2 Inhibitors: Drug Class, Uses, Side Effects, Drug Names - RxList
Vesicular monoamine transporter 2 (VMAT2) inhibitors are drugs used for treating uncontrolled, involuntary movements associated with Huntington’s disease, tardive dyskinesia, or Tourette’s …
Tetrabenazine, the first VMAT-2 inhibitor, was approved in 2008 for Huntington’s chorea and is used off-label for the treatment of TD. Deutetrabenazine and valbenazine were FDA approved …
Valbenazine: Uses, Dosage, Side Effects, Warnings - Drugs.com
May 3, 2024 · Valbenazine is a type of drug called a VMAT2 (vesicular monoamine transporter 2) inhibitor. It is thought to work by preventing the release of dopamine from small structures …
The vesicular monoamine transporter 2: an underexplored …
Novel VMAT2 inhibitors that are specific to each monoamine (i.e. a serotonergic specific VMAT2 inhibitor) may have improved efficacy for the treatment of hypermonoaminergic disorders. …
Drug inhibition and substrate transport mechanisms of human VMAT2
3 days ago · TBZ, the first VMAT2 inhibitor approved by FDA, was sanctioned for the treatment of chorea associated with Huntington’s disease in 2008 and has also been used off-label to …
Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and …
Nov 23, 2022 · Here we report the identification of several approved drugs, notably β2-adrenergic agonists salmeterol, vilanterol and formoterol, β2-adrenergic antagonist carvedilol and the …
Austedo: Uses, Dosage, Side Effects & Warnings - Drugs.com
5 days ago · Austedo (deutetrabenazine) is an oral prescription medication approved to treat Huntington’s chorea and tardive dyskinesia (TD). Austedo is classified as a vesicular …
Vesicular Monoamine Transporter 2 (VMAT2) Inhibitors
Apr 2, 2019 · The vesicular monoamine transporter type 2 (VMAT2) inhibitors are agents that cause a depletion of neuroactive peptides such as dopamine in nerve terminals and are used …